---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-042932"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2026-06-12T21:00:14+00:00"
generated_at: "2026-06-12T21:04:22.329630+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# All six director nominees elected, Deloitte ratified, say-on-pay approved at Ginkgo 2026 annual meeting

## Summary
- Shareholders present: 39.5M Class A and 8.4M Class B shares, representing 77.15% of combined voting power.
- All six directors elected: Jason Kelly and Reshma Shetty (Class B vote), Ross Fubini, Christian Henry, Sri Kosuri, Harry E. Sloan (single class).
- Ratification of Deloitte & Touche as auditor for FY2026 approved: 119.5M for, 267k against, 3.8M abstentions.
- Advisory vote to approve executive compensation passed: 95.1M for, 12.5M against, 4.2M abstentions (broker non-votes 11.8M).

## SEC filing metadata
- accession: 0001628280-26-042932
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2026-06-12T21:00:14+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/0001628280-26-042932-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/dna-20260611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-042932
- JSON: https://secwatch.observer/filing/0001628280-26-042932.json
- Plain text: https://secwatch.observer/filing/0001628280-26-042932.txt

## Key facts
- Shareholder Votes
  Ginkgo Bioworks Holdings, Inc. shareholders approved Advisory vote to approve the compensation of the Company’s named executive officers.
  - Proposal: say on pay
  - Outcome: passed
  source text: Pursuant to the foregoing vote, the compensation of the Company’s named executive officers was approved on an advisory basis.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/0001628280-26-042932-index.htm
- Shareholder Votes
  Ginkgo Bioworks Holdings, Inc. shareholders approved Election of six nominees to serve as directors at the 2026-06-11 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-11
  source text: Pursuant to the foregoing votes, the six nominees listed above were elected to serve on the Company’s Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/0001628280-26-042932-index.htm
- Shareholder Votes
  Ginkgo Bioworks Holdings, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-12-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-12-31
  source text: Pursuant to the foregoing vote, the ratification of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/0001628280-26-042932-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.